ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Site-Specific Chemical Conjugation of Antibodies by Using Affinity Peptide for the Development of Therapeutic Antibody Format

https://repo.qst.go.jp/records/75969
https://repo.qst.go.jp/records/75969
5fcb9404-11b6-4973-bf94-95ecbba49b17
Item type 学術雑誌論文 / Journal Article(1)
公開日 2019-06-04
タイトル
タイトル Site-Specific Chemical Conjugation of Antibodies by Using Affinity Peptide for the Development of Therapeutic Antibody Format
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Kishimoto, Satoshi

× Kishimoto, Satoshi

WEKO 865537

Kishimoto, Satoshi

Search repository
Nakashimada, Yuichi

× Nakashimada, Yuichi

WEKO 865538

Nakashimada, Yuichi

Search repository
Yokota, Riri

× Yokota, Riri

WEKO 865539

Yokota, Riri

Search repository
Hatanaka, Takaaki

× Hatanaka, Takaaki

WEKO 865540

Hatanaka, Takaaki

Search repository
安達, 基泰

× 安達, 基泰

WEKO 865541

安達, 基泰

Search repository
Ito, Yuji

× Ito, Yuji

WEKO 865542

Ito, Yuji

Search repository
Adachi, Motoyasu

× Adachi, Motoyasu

WEKO 865543

en Adachi, Motoyasu

Search repository
抄録
内容記述タイプ Abstract
内容記述 Artificially modified IgG molecules are increasingly utilized in industrial and clinical applications. In the present study, the method of chemical conjugation by affinity peptide (CCAP) for site-specific chemical modification has been developed by using a peptide that bound with high affinity to human IgG-Fc. This method enabled a rapid modification of a specific residue (Lys248 on Fc) in a one-step reaction under mild condition to form a stable amide bond between the peptide and Fc. The monovalent peptide-IgG conjugate not only maintained complete antigen binding but also bound to Fc receptors (FcRn, FcγRI, and FcγRIIIa), indicating that it is a suitable conjugate form that can be further developed into highly functional antibody therapeutics. CCAP was applied for the preparation of an antibody-drug conjugate and a bispecific antibody to demonstrate the usefulness of this method.
書誌情報 Bioconjugate Chemistry

巻 30, 号 3, p. 698-702, 発行日 2019-03
出版者
出版者 ACS publications
ISSN
収録物識別子タイプ ISSN
収録物識別子 1043-1802
PubMed番号
識別子タイプ PMID
関連識別子 30616340
DOI
識別子タイプ DOI
関連識別子 10.1021/acs.bioconjchem.8b00865
関連サイト
識別子タイプ URI
関連識別子 https://pubs.acs.org/doi/10.1021/acs.bioconjchem.8b00865
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 18:08:31.710636
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3